Supplementary
anti-human CD3-PE, mouse IgG2a monoclonal Immunotools (21850034) anti-human CD19-APC, mouse IgG1 monoclonal Immunotools (21270196) anti-human CD19-FITC, mouse IgG1 monoclonal Immunotools ( were left untreated or were stimulated for 1, 5 or 10 minutes with 10 nM E2, 50 nM SHBG, or E2 in complex with SHBG. Cell lysates were then subjected to immunoblotting. Two blots were run in parallel; one for anti-pERK1/2 the other for anti-pAkt antibodies. The blots were re-probed with antiactin to ensure equal loading. Non-treated cells, NT.
